CDH17 and gastric adenocarcinoma: In another work, the same group proposed a dual electrochemical immunoassay for the simultaneous detection of IL-13Rα2 and cadherin-17 (CDH-17) an important cancer biomarker involved in several tumor processes with different metastatic potential and also a sensitive marker for gastric adenocarcinoma [129].